Literature DB >> 4398328

Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment.

J V Beardsley, F Puletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4398328     DOI： 10.1001/archneur.1971.00490020063007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  10 in total

Review 1.  The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.

Authors:  Claudio Da Cunha; Miriam Elizabeth Mendes Angelucci; Newton S Canteras; Susan Wonnacott; Reinaldo N Takahashi
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 2.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 3.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

4.  [General intelligence of patients with parkinsonism during L-dopa medication (author's transl)].

Authors:  P Jacobi; P A Fischer; E Schneider
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974

5.  Recognition memory in Parkinson's disease.

Authors:  K A Flowers; I Pearce; J M Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

6.  Cognitive and motor shifting aptitude disorder in Parkinson's disease.

Authors:  A R Cools; J H van den Bercken; M W Horstink; K P van Spaendonck; H J Berger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

7.  The effect of Parkinson's disease on the ability to maintain a mental set.

Authors:  K A Flowers; C Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

8.  Dopamine correlates of neurological and psychological status in untreated Parkinsonism.

Authors:  M M Hoehn; T J Crowley; C O Rutledge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-10       Impact factor: 10.154

9.  Confusion, dementia and anticholinergics in Parkinson's disease.

Authors:  Y de Smet; M Ruberg; M Serdaru; B Dubois; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

10.  Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.

Authors:  D Prasher; L Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.